Phase 1 Thyroid Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 to 80 years old, of any gender
- People who have been diagnosed with medullary thyroid cancer (a type of thyroid cancer), confirmed through laboratory testing of tissue samples
- People whose medullary thyroid cancer has come back after previous treatment
- People who are willing and able to sign a written consent form agreeing to participate
Who may not be able to join:
- Women who are pregnant or currently breastfeeding
- People who experience significant anxiety or distress in enclosed spaces (such as during a scan)
- People who are unwilling or unable to provide written consent, including cases where a parent or legal representative is also unable or unwilling to do so
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Weibing Miao, First Affiliated Hospital of Fujian Medical University
Phone: 86-0591-87981618
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
SUVmax and SUVpeak
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.